Thursday, November 2, 2017

Regulatory frameworks governing the supply of therapeutic goods

Last lecture for the year- and possibly for my undergrad!

What is a therapeutic good?

A therapeutic good is anything that is used for a therapeutic use, such as treatment, prevention or diagnosis of diseases, testing susceptibility to diseases, contraception and pregnancy tests. Even stuff like band-aids and thermometers are considered to be therapeutic goods.

Sometimes things can get a bit complicated. Let's start with foods. If you have a clove of garlic, that is food. If you concentrate part of the garlic, put it into capsule form and make a therapeutic claim (e.g. "can relieve cold and flu symptoms"), you now have a therapeutic good. Cosmetics can also be a bit confusing: moisturisers are normally cosmetics, but if they contain a sunscreen agent and claim to protect from UV radiation, they become classified as a therapeutic good. In short: the principal use and presentation of a product are important in determining whether something should be classified as a "therapeutic good" or not.

To make things even more confusing, there are some products that you would think should be therapeutic goods, but aren't. Hair products, such as bleaches and dyes, as well as some dental products, such as whiteners, are excluded from being classified as therapeutic goods. Breath testers used by police are also exempt, as is reproductive tissue for use in assisted reproductive therapy. Fresh, viable organs are exempt, though an organ that has been stored for a while is classified as a therapeutic good.

Why is regulation of therapeutic goods important?

It is important to regulate therapeutic goods so that we can (hopefully) prevent dodgy drugs from making it to market, or we can at least recall them quickly if they turn out to be problematic. Here are some examples of therapeutic goods that turned out to be problematic:
  • Thalidomide- Perhaps the most well-known example. Thalidomide was originally created to treat morning sickness. However, it also caused babies to be born without limbs (or with deformed limbs), due to anti-angiogenic effects. Interestingly, thalidomide is sometimes used as an anti-cancer drug because of its anti-angiogenic effects.
  • Vioxx- Originally created to treat rheumatoid arthritis and other forms of chronic inflammation, Vioxx was withdrawn when it was found to increase the risk of cardiovascular disease.
  • Porcine small intestine submucosa (SIS)- SIS was advertised as an acellular scaffold for cell therapies. However, it was found to contain porcine DNA, resulting in inflammatory responses.
  • Metal-on-metal hip implants- Metal-on-metal implants were found to release small metal particles into the bloodstream.
  • Poly implant prosthesis (PIP) breast implants- These breast implants had the risk of exploding.
Regulation of therapeutic goods

To be honest, I mainly just zoned out here. Main points are that the main regulator in Australia is the Therapeutic Goods Administration (TGA). Their main concerns are quality, safety, efficacy and cost. All of these factors are taken into consideration when evaluating a new therapeutic good and when monitoring an existing good.

There are three main categories of therapeutic goods: medicines, medical devices and biologicals. Medicines include prescription and over-the-counter drugs, vaccines, blood and blood components, and animal cell and tissue-derived products. Medical devices include blood pressure monitors, cardiac pacemakers, surgical gloves, breast implants, condoms and human tissues used in diagnostics. Biologicals are things that are made from human cells and/or human tissues (aside from human tissues used in diagnostics).

And that's the last post for the semester! Good luck in exams!!

Tuesday, October 31, 2017

Infant Nutrition and Functional Foods

Last post for PHYL3003!

Definitions

First up, some definitions for some extra clarity:
  • Infant- A child aged between 0-12 months.
  • Newborn or neonate- An infant in the first 28 days of life.
  • Preterm- Infant born before 37 weeks gestation.
  • Very preterm- Infant born between 28 weeks and 31 weeks + 6 days gestation.
  • Extremely preterm- Infant born before 28 weeks gestation.
Babies who are born very or extremely preterm may need to be fed parentally at first, and then drip-fed milk. Premature babies may have underdeveloped GI tracts that cannot handle a rapid feed, so feeding them rapidly may increase the risk of necrotising enterocolitis (NEC).

Breastmilk

You've probably heard the saying that "breast is best." In fact, the World Health Organisation and UNICEF recommend that babies are fed exclusively breast milk in the first six months of life, and that breast milk continues to be the primary food for the first year of life. It is also recommended to continue to breastfeed for two years or even longer.

Why is breast milk so good? It's got lots of good stuff in it, such as:

Proteins

Proteins, which are found in higher concentrations in colostrum (milk in first few days after giving birth) as compared to regular breast milk, are needed for growth of lean tissue. The main proteins in breast milk are caseins, whey proteins and milk fat globule proteins. Important whey proteins include lactoferrin, alpha-lactalbumin, lysozyme, secretory IgA and bile-salt-stimulated lipase. Lactoferrin binds to iron, reducing the amount of iron available for pathogens, and thus has bacteriostatic effects. Alpha-lactalbumin has a good amino acid profile, making it suitable for promoting the growth of the gut microbiome. Lysozyme and secretory IgA both have important immune functions, while bile-salt-stimulated lipase aids in the digestion of milk lipids. Whey proteins are somewhat resistant to digestion by the baby's gut, so they can hang around and exert their goodness for a while.

Carbohydrates

The main carbohydrate in breast milk is lactose, but it isn't the only one. Other important carbohydrates include the human milk oligosaccharides (HMO), which consist of a large variety of oligosaccharides (3-10 monosaccharides) that are resistant to digestion. HMOs are prebiotic (support growth of the gut microbiome), inhibit virus and bacteria binding, and are a source of sialic acid, which supports brain development and cognition. At least one HMO is associated with reduced risk of necrotising enterocolitis.

Fats

Breast milk contains plenty of saturated and polyunsaturated long-chain fatty acids. The total fat content is independent of the maternal diet, but the fatty acid profile depends on maternal diet, so mothers should make sure to eat a diet with a good fatty acid profile. Fats are actively transported from the maternal blood through lactocytes in order to get to the milk.

The main saturated fatty acids in breast milk are palmitic and stearic acids, which are important energy sources. Around 60% of palmitic acid in human breast milk is esterified at the sn-2 position of glycerol, which is different to cow's milk and formula in which esterification occurs at sn-1 and sn-3. It is thought that the esterification in cow's milk and formula may increase calcium binding to palmitate, leading to hard stools in babies fed formula (as opposed to breast milk).

The main polyunsaturated fatty acids in breast milk include linoleic and linolenic acids (both essential fatty acids), decosahexanoic acid (DHA) and eicosapentanoic acid (EPA) (incorporated into cell membranes and are essential for retinal and brain development), and arachidonic acid. The optimal ω-6/ω-3 ratio is around 5.

Micronutrients

Breast milk contains a lot of micronutrients such as vitamins, iron and iodine. However, the concentrations of such nutrients depends on the mother's diet.

Prebiotics?

Breast milk contains bacteria that may be important for the gut health of the infant. This is still a growing area of research, so watch this space...

"Nutritional supplements" for infants

Unfortunately, not all mothers can breastfeed, for various reasons. As such, other possible "supplements" are being researched. Bovine colostrum has been shown to be beneficial in neonatal growth, digestive function and gut immunity, while bovine lactoferrin (which is 70% homologous with human lactoferrin) may reduce the risk of necrotising enterocolitis.

Formula

Formula is pretty much always the go-to for mothers who cannot breastfeed. All formulae have certain nutrients that are required by law. In addition, there are laws that state that no health claims can be made for formulae designed for infants (i.e. <12 months of age).

Introducing solids

Solids can be introduced at around 6 months, or even slightly earlier. It is important that the first foods given are rich in protein and iron, as these are the first nutrients to become deficient. Foods can be introduced in pretty much any order, at a rate that suits the infant. Once the child is older than 12 months, they can usually eat the same foods as the rest of the family.

Only one more content lecture left for the rest of semester (for PATH3304)! Almost there!

The Future of Infectious Diseases

Last post for MICR3350! This semester's been a wild ride!

We've come a long way in diagnosis and treatment of infectious diseases. Diseases that used to be major causes of death and disability are not as bad today, and one (smallpox) has been eradicated entirely (well, unless you count smallpox samples in labs). That being said, there's always room for improvement with regards to diagnosis, treatment, prevention and eradication.

Diagnosis

The quicker we diagnose something, the quicker we can give appropriate treatment. Therefore, we are always looking to find ways to diagnose diseases more rapidly.

Sepsis

Traditional diagnosis of sepsis ("a toxic inflammatory condition arising from the spread of bacteria or bacterial toxins from the focus of infection") relies on culture, which normally takes at least 24-48 hours. Possible rapid diagnostic tests that can be done instead include direct detection of biomarkers and point-of-care testing. Point-of-care testing might be done at a dedicated point-of-care lab that is closer than a central diagnostic lab, or it might be done at the bedside via a range of hand-held devices. For example, a portable "microscope" has been developed that sends light through a blood drop and can detect the interaction of light with blood components. Another possible device is the CD64 biochip which detects CD64 expression on neutrophils. The CD64 biochip can provide results after around 30 minutes.

Tuberculosis

Conventional TB diagnosis requires chest X-ray as well as sputum microscopy and culture. Since mycobacteria take a long time to grow, quicker tests, such as urine and breath tests, are being developed. Urine tests can be done to detect lipoarabinomannan (LAM), a component of the M. tuberculosis cell wall. These tests can give results in 25 minutes. Breath tests can look for metabolic products of M. tuberculosis, such as naphthalene derivatives, benzene and alkanes. Such breath tests can give results in six minutes- a far cry from the weeks required to culture M. tuberculosis!

Treatments

Unfortunately, not much has happened in the way of developing new antibiotics, despite new technologies for drug discovery, such as "iChips." One antibiotic that has been developed using the "iChip" is teixobactin, which was derived from soil microbes. Another relatively recent antibiotic is Baxdela, or delafloxacin, which is a fluoroquinolone.

Prevention

Public health campaigns and other preventative measures such as vaccines have helped to bring down the rate of infectious diseases. Unfortunately, there are many diseases that we don't have vaccines for yet, such as HIV/AIDS. HIV is highly mutable and very variable, making it difficult to produce a vaccine. There is also a lack of natural immunity to HIV that can be exploited with a vaccine. Other production issues for an HIV vaccine include a lack of an animal model, non-antigenicity of heat-killed HIV-1, and safety concerns with a live attenuated vaccine.

Eradication

As you most likely know, smallpox has been declared eradicated. Factors contributing towards smallpox eradication include an effective vaccine, good surveillance and the fact that humans are the only host. (If animals are also hosts, then you have to vaccinate all of the animals too, which can be tricky.) There are current global eradication programs for polio, malaria, Guinea worms and Yaws (caused by T. pallidum pertenue). Wild poliovirus type 2 has already been eradicated worldwide and type 3 hasn't been seen since 2012 (so it may be declared eradicated soon), but type 1 is still circulating in some countries, notably Pakistan, Nigeria and Afghanistan. The Democratic Republic of the Congo and Syria have also experienced outbreaks.

And that's it for MICR3350!! Good luck in the exam!

TB and HIV

Second last post for MICR3350!

Tuberculosis (TB)

TB has been around for a while (there are 5000-year-old mummies that have evidence of TB infection), but it wasn't always called TB. It used to be called phthisis pulmonalis or consumption, and may have been transmitted between animals and humans. The causative agent, M. tuberculosis, was first identified by Robert Koch, who was awarded the Nobel Prize in Physiology or Medicine for his discovery.

Presentation

M. tuberculosis is an aerobic, non-motile, rod-shaped bacterium. It has a unique cell wall structure, which makes it resistant to most typical stains, such as the Gram stain. The main defining feature of the M. tuberculosis cell wall is the presence of mycolic acids, which resist drying, acids, alcohol and lytic enzymes. M. tuberculosis cell walls also have a unique component called lipoarabinomannan (LAM), which has been investigated as a possible diagnostic sign.

The most common form of tuberculosis is pulmonary tuberculosis. Pulmonary TB is characterised by chronic cough, haemoptysis (coughing up blood), fever, night sweats, loss of appetite and weight loss. It can be diagnosed by the presence of "Ghon foci" in a lung X-ray, as well as granulomatous lesions and caseous necrosis (especially in active infection). Pulmonary TB can persist for months. Extra-pulmonary TB, which is more common in patients who are also HIV+, affects all organs and may cause meningitis and lymph node disease. "Potts Disease" is TB that affects the spine.

TB can be transmitted via respiratory droplet nuclei, which is why most infections are in the lungs. TB can grow within macrophages to evade the immune system, and from there it can spread via the blood to various organs of the body. Around 10% of infections will become symptomatic, but the remaining ~90% remain latent. It is estimated that around 1/3 of the world's population have latent TB. Only people with active TB can transmit the disease, and it is estimated that every active case results in around 10-15 transmissions per year.

Diagnosis

Specimens used for TB diagnosis include sputum and biopsy. Tests done include microscopy and culture, though culture of mycobacteria can take a long time. Therefore, molecular tests such as PCR and special blood tests such as the Quantiferon TB-Gold blood test (which detects cell-mediated immune response) are increasingly being used.

Treatment

Treatment of tuberculosis requires prolonged therapy (6 months or more). The first phase, the induction phase, lasts around 2 months. In this phase, patients are given rifampicin, isoniazid, pyrazinamide and sometimes ethambutol (if the organism is not sensitive to rifampicin and isoniazid). This cocktail of drugs results in a cure rate of over 90%. In the consolidation phase, which lasts for around 4 months, patients are given rifampicin and isoniazid. The consolidation phase may continue for over a year if patients present with meningitis.

Drug resistance

Unfotunately, TB is gaining resistance to many treatments. MDR-TB (multi-drug resistant TB) is resistant to at least rifampicin and isoniazid. XDR-TB (extensively drug resistant TB) is resistant to rifampicin, isoniazid, fluoroquinolones and at least one anti-TB injectable drug. Finally, XXDR-TB is totally drug resistant.

Human Immunodeficiency Virus (HIV)

HIV is a lentivirus of the retroviridae (retrovirus) family. As such, it is an RNA virus that uses reverse transcriptase to convert its genome into DNA and integrate into the host genome.

The two types of HIV are HIV-1 and HIV-2. HIV-1 is the most common cause, and is very similar to a chimpanzee retrovirus called SIVcpz. HIV-2 is much less common as it is less transmissible and less severe, and is largely confined to West Africa. It is similar to a virus in Sooty Mangabey monkeys called SIVsm. The most common forms of HIV transmission are sexual intercourse, intra-uterine, childbirth and sharing needles. Breastfeeding may also pose a risk, but there is still some controversy surrounding this.

As I have stated in other posts, HIV infects many cells, but particularly CD4+ cells, such as T-helper cells. CD4 falls by around 40-80 cells/μL per year, leading to impaired cell-mediated immunity and a higher risk of opportunistic infections. Opportunistic infections mainly appear when CD4+ cell count falls beneath 200 cells/μL, which normally happens around 6-10 years after diagnosis.

HIV is diagnosed primarily through detection of HIV antibodies or HIV p24 antigen via ELISA. These tests are then confirmed by a Western blot assay which has high specificity. The Western Blot used for HIV detects antibodies to all three major HIV gene products: gag, pol and env. Treatment response can be monitored by looking at CD4 count and at HIV RNA PCR. The goal for HIV RNA PCR is for an "undetectable viral load," or less than 40 copies/mL.

There are a range of treatments for HIV. These include NRTIs, NNRTIs, protease inhibitors, integrase inhibitors and entry inhibitors. However, I will not go into these drugs in further detail in this post.

TB and HIV

There is a profound interaction between TB and HIV. Over 25% of TB deaths are in patients who are HIV+, and around 80% of TB infections are co-infected with HIV. TB patients who are HIV+ have a 10% chance of TB reactivation every year, which is very different to HIV- patients who have a less than 5% risk of reactivation in their lifetime. HIV+ patients also have an increased risk of drug-resistant TB. Nevertheless, treatment for TB is the same in HIV+ and HIV- patients.

Thursday, October 26, 2017

The Ins and Outs of Ethanol

Last post for PHYL3004! This post will discuss the favourite drug of many students worldwide- ethanol!

What factors govern absorption of ethanol into the blood stream?

Ethanol is quite water-soluble due to its -OH group. It is also fairly lipid-soluble due to its CH3CH2- group. As ethanol is a small, uncharged molecule, it is also able to cross cell membranes and have an effect on the various tissues of our body without requiring any kind of chemical modification.

Ethanol is absorbed into the circulation via passive diffusion. Most (~80%) is absorbed through the small intestine, whereas the remaining 20% is absorbed in the stomach wall. As such, factors governing ethanol absorption are the same as factors governing diffusion in general: concentration gradient, permeability, and surface area. Most ethanol is absorbed in the intestines because the intestines have a much larger surface area than the stomach.

You've probably heard the advice to "never drink on an empty stomach." But why is this? Ethanol is absorbed more slowly after eating. This is because the presence of food in the stomach delays gastric emptying, allowing ethanol to remain in the stomach longer, where it is absorbed at a slower rate. The slower rate of ethanol absorption allows the body more time to metabolise any ethanol that has already been absorbed, which also reduces the peak of blood alcohol concentration.

The distribution of ethanol into various tissues depends on the relative water content of the tissue. Ethanol is both water- and lipid-soluble, as I said earlier, but it is more water-soluble than lipid-soluble. Therefore, it is highly soluble in the blood but has low solubility in fats. Females tend to have a reduced body water compared to males due to increased fat mass and decreased muscle mass (muscle cells have more water than fat cells). Therefore, blood alcohol concentration increases more for females than for males, which is why females are recommended to have fewer drinks than males. Similarly, other populations with reduced muscle mass (e.g. elderly) may also be more susceptible to the effects of alcohol.

What are the determinants of peak blood alcohol concentration?

Blood alcohol concentration is, well, the concentration of alcohol in the blood. It is usually given as a percentage. The legal driving limit in Australia is 0.05%, or 0.05g per 100mL of blood.

I've already hinted at a couple of determinants of peak blood alcohol concentration: stomach fullness and the proportion of fat and muscle. The obvious other determinant of blood alcohol concentration is the number of standard drinks consumed. 1 standard drink is equivalent of 10g of pure alcohol.

Why is the brain susceptible to the effects of ethanol (beginning with the blood-brain barrier)?

Before ethanol gets anywhere near the central nervous system, it already has effects on sensory nerves. Remember how capsaicin stimulates the sensation of heat? Ethanol works through the same pathway, stimulating TRPV1 receptors (i.e. vallinoid receptors, the same receptors stimulated by capsaicin).

Ethanol can cross the blood-brain barrier as it is a small, uncharged molecule. Once in the brain, it causes inhibition by enhancing the activation of inhibitory GABAA receptors and suppressing the activation of excitatory glutamate receptors. Alcoholics have an adaptive response in which their brain increases its level of excitation. During withdrawal, these compensatory excitatory effects persist long after inhibition by alcohol has ceased, causing withdrawal symptoms.

How is ethanol removed from the body?

Ethanol is not stored- it just hangs around until it gets removed. Most of this removal (~90%) is via metabolism, most of which occurs in the liver. In the liver, alcohol is converted into acetaldehyde by alcohol dehydrogenase (ADH), and acetaldehyde is then converted into acetate via aldehyde dehydrogenase (ALDH). Both of these reactions require NAD+ as a cofactor. As ADH is also expressed in the stomach, a small amount of ethanol is metabolised in the stomach before absorption, reducing the total amount of ethanol absorbed. Interestingly enough, the efficacy of ADH is reduced in alcoholics.

The remaining ~10% of ethanol is excreted unchanged in the urine, breath or sweat. The concentration of ethanol in the blood is the same as in the urine. Urinary clearance is only around 1mL/min, so it's a good thing that we have so many other mechanisms to get rid of alcohol.

Removal of alcohol via the breath is quite unique. While oxygen and carbon dioxide enter the alveoli via the pulmonary circulation, ethanol actually diffuses across the airways from the bronchial circulation. We know this because a graph of breath ethanol concentration shows an exhalation pattern more similar to airway gas exchange than alveolar gas exchange. In alveolar gas exchange, there is an initial plateau (dead space air), a steep increase in concentration (due to transition from dead space air to alveolar air) and a final plateau (alveolar air). In airway gas exchange, like in ethanol, the initial plateau is absent, the steep increase represents the conducting airways, and the plateau phase represents alveolar air that has been modified in the exchange zone. Furthermore, the location of gas exchange appears to depend on the liquid to gas partition ratio, or λ. The blood and water solubility for ethanol (which is exchanged in the airways) is far greater than for oxygen or carbon dioxide (which are absorbed in the alveoli).

In airway exchange of ethanol, ethanol first moves into the airway surface liquid that lines the airways and humidifies inspired gas. Ethanol then moves down the airways during inspiration (as this means that it is moving down its concentration gradient). Movement of ethanol down the airways causes saturation of alveolar air with ethanol, so there is no concentration gradient in the alveoli. Therefore, there is no alveolar exchange of ethanol.

And I think that's it! Good luck in exams!

Problems with Gene Therapy

Final lecture before the test! This lecture was super light on content- most of the slides (and there were only 14) included a bunch of ethical questions to think about as well as links to other associations for students who want more information. I'm just going to deal with the content part, so this will be a short blog post.

Factors that have slowed gene therapy development

Despite decades of research into gene therapies, several factors have hindered development of actual treatments. For starters, most corrections are only short-lived, particularly when whole-cell transplantation is used as the cells may be attacked by the immune system. Therefore, multiple doses are normally needed, which might be difficult due to said immune response. Delivery to cells can also be problematic as you need a vector that can accommodate the desired gene and deliver it to its target. Furthermore, most target cells are somatic, non-dividing cells, so the correction won't be propagated. Finally, many diseases involve multiple genes, and possibly a combination of genes and environmental factors, making it difficult to design a gene therapy.

Since I just mentioned vectors, I'll go into vectors in a bit more detail. As mentioned here, the main vectors used are adenoviruses, AAVs, HSV and retroviruses. All of these (except for AAVs) can provoke immune responses. Retroviruses can be particularly problematic as they randomly integrate into the genome (unlike AAVs which always integrate into chromosome 19), which may interrupt a normally functioning gene.

New developments that are helping gene therapy

Of course, it's not all gloom and doom. Several strategies are being used to help the development of gene therapy. For example, as mentioned here, siRNAs, exon skipping, and CRISPR-Cas9 have all been explored for their potential to alter gene expression. Another factor helping gene therapy development is improved liposomal targeting of the brain, which may help treat Parkinson's and Alzheimer's. Yet another new development is Chimeric Antigen Receptor (CAR) T-cell therapy, in which T-cells are isolated from the patient, engineered to express chimeric antigen receptors (CARs) that recognise cancer cells, and reinfused into the patient.

Not many gene therapy drugs have made it through to market, but here's a few that have:
  1. Glybera was the first drug to make it to market (in 2012). It is a treatment for lipoprotein lipase (LPL) deficiency, and consists of a human LPL gene delivered by an AAV1 viral vector.
  2. Kymriah is a CAR drug used to treat acute lymphoblastic leukaemia (ALL).
  3. Yescarta is another CAR drug used to treat large B-cell leukaemia.

Gene Therapy and Immunocontraception

This lecture was pretty interesting! Probably my favourite lecture from this unit :D

Why immunocontraception?

Immunocontraception has been proposed as a potential solution to dealing with pests. For example, mouse plagues are a problem in grain-growing regions of Australia. In the past, they used to be dealt with using a poison called strychnine, but the use of strychnine has since been banned due to the risk of contamination. Currently mouse populations are monitored by using canola cards (the more chewed up the card, the bigger the problem you have), and controlled by using zinc phosphide and bromodiolone. In the USA, wild horse populations are problematic, and control measures may be needed.

Autoimmunity and infertility

Studies have shown that antibodies against the zona pellucida (ZP) are associated with infertility. The zona pellucida is a glycoprotein layer that surrounds the oocyte, providing protection from polyspermy. In mice, the zona pellucida is formed from three genes: ZP1, ZP2 and ZP3. ZP1 is associated with structural integrity, and loss of structural integrity occurs if ZP1 is knocked out. ZP2 and ZP3 alternate to form chains that make up the bulk of the zona pellucida. If ZP2 is knocked out, the early ZP is thin, and later on it is absent entirely. If ZP3 is knocked out, the ZP fails to form. In both ZP2 and ZP3 knockout, infertility results.

Studies have shown that ZP3 from a different species can be used as an "infertility vaccine" for large animals that can be vaccinated individually, such as horses. (It's a tad harder to vaccinate individual mice during a mouse plague). To address this problem, virally vectored immunocontraception was explored instead. The idea behind this process is that the DNA encoding reproductive proteins can be inserted into a virus, which can then be used to infect mice. When mice develop an immune response against the virus, they will also develop an immune response against the protein.

rMCMV-mZP3

Many immunocontraception studies examined the use of ZP3 as an antigen. This is because monoclonal antibodies to ZP3 have been shown to prevent oocyte fertilisation (both in vivo and in vitro), and immunisation with ZP3 peptide conjugated to Keyhole limpet haemocyanin also causes infertility. The vector used was MCMV (mouse cytomegalovirus), as it has a large genome (~235kb), is a natural pathogen of mice in Australia, and mice can be infected by multiple strains. It is also a persistent, latent infection, so it'll hang around for a while. MCMV containing ZP3 DNA is also known as rMCMV-mZP3.

rMCMV-mZP3 was found to induce infertility over the long term. By day 7, degradation of the zona pellucida was evident, by day 21, primary follicles had decreased, secondary follicle morphology was abnormal and tertiary follicles were absent, and by day 100, primary and secondary follicles were markedly reduced, there were no tertiary follicles, and there were evident changes to the histology of the ovary. Gap junctions between the zona pellucida and ovary also failed to form. Induced antibody titre was found to increase the effect of infertility. Furthermore, mice who could not produce antibodies were not rendered infertile by this method.

Unfortunately, viral growth using rMCMV-mZP3 was very poor. One possible explanation is that expression of the foreign antigen led to an increased immune response from the mouse, resulting in poor viral growth. Because viral growth was poor in the saliva, mice did not spread this virus by biting each other (which is how MCMV is usually spread). Therefore, this method of immunocontraception was unable to provide widespread contraception of mice.

Another thing that was learned from this study is that the viral vector used is important. Mice who have innate resistance to the viral vector have a reduced response. The Cmv1 locus appears to be important in MCMV resistance. BALB/c mice have a more profound response to rMCMV-mZP3 as compared to C57BL/6, which have a more "resistant" allele on the Cmv1 locus. However, when C57BL/6 mice were given the G4 (Geraldton) strain of MCMV, which they were not resistant to, they had a strong response to the immunocontraceptive therapy.

Only one more lecture to cover before the test tomorrow!